Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children

European Journal of Endocrinology

Volumn 134, Issue 6, 1996, Pages 716-719

  Klinger, Beatrice ^a   Silbergeld, Aviva ^a   Deghenghi, Romano ^b   Frenkel, Jenny ^a   Laron, Zvi ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b Ardana   (France)

^c Pediat Endocrinol and Diabet Res   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HEXARELIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; FEMALE; GROWTH RATE; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SHORT STATURE;

EID: 0029994796     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340716     Document Type: Article

References (15)

1. Deghenghi R, Cananzi MM, Torsello A, Battisti C, Muller EE, Locatelli V. GH-releasing activity of hexarelin, a new growth hormone peptide, in infant and adult rats. Life Sci 1994;54: 1321-8
2. Ghigo E, Arvat E, Gianotti L, Ramunni J, Di Vito L, Imbimbo BP, et al. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. J Clin Endocrinol Metab 1994;78:693-8
3. Laron Z, Frenkel J, Gil-Ad I, Klinger B, Lubin E, Withrich P, et al. Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin). Clin Endocrinol 1994;41: 539-41
4. Frenkel J, Silbergeld A, Deghenghi R, Laron Z. Short term effect of intranasal administration of hexarelin - synthetic growth hormone-releasing peptide. Preliminary communication. J Pediatr Endocrinol Metabol 1995;8:43-5
5. Laron Z, Frenkel J, Deghenghi R, Amin S, Klinger B, Silbergeld A. Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clin Endocrinol 1995;43:631-5
6. De Bell WK, Pezzoli SS, Throner MO. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation. J Clin Endocrinol Metab 1991;72: 1312-6
7. Jaffe CA, Ho J, Demott-Friberg R, Bowers CY, Barkan AL. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab 1993;77:1641-7
8. 2 in children with idiopathic short stature induces a sustained increase in growth velocity. Clin Endocrinol 1994;41:487-93
9. Laron Z, Klinger B, Jensen LT, Erster B. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism. Clin Endocrinol 1991;35:145-50
10. Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984;114:1537-45
11. Bowers CY. GH releasing peptides - structure and kinetics. J Pediatr Endocrinol 1993;6:21-31
12. Arsenjevic Y, Rirest RW, Eshkol A, Sizonenko PC, Aubert ML. Plasma growth hormone (GH) response to intravenous GH releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation. Endocrinology 1987;121:1487-96
13. Laron Z. Growth hormone releasing peptides: clinical experience and therapeutic potential. Drugs 1995;50:595-601
14. Laron Z, Topper E, Gil-Ad I. Oral clonidine - a simple, safe and effective test for growth hormone secretion. In: Laron Z, Butentandt O, editors. Pediatrics and adolescent endocrinology. vol 12. Basel: Karger, 1983;103-15
15. Josefsberg Z, Kauli R, Keret R, Brown M, Bialik O, Greenberg D, et al. Tests for hGH secretion in childhood. In: Laron Z, Butentandt O, editors. Pediatric and adolescent endocrinology. vol 12. Basel: Karger, 1983;66-74